TBI— 510(k) K232669

Substantially Equivalent

Abbott Laboratories

FDA 510(k) clearance K232669 for TBI, Substantially Equivalent on 2023-09-29. Applicant: Abbott Laboratories.

Clearance details

Applicant: Abbott Laboratories
Product code: Code QAT
Advisory panel: Immunology
Date received: 2023-09-01
Decision date: 2023-09-29
Decision: Substantially Equivalent
Clearance type: Special
Location: Abbott Park, IL, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.